Arimoclomol in Amyotropic Lateral Sclerosis
Public ClinicalTrials.gov record NCT03491462. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomised, Placebo-Controlled Trial of Arimoclomol in Amyotropic Lateral Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A multicenter, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of arimoclomol in amyotropic lateral sclerosis (ALS)
Study identification
- NCT ID
- NCT03491462
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 245 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2018 (Actual)
- Primary completion
- Dec 18, 2020 (Actual)
- Completion
- Dec 18, 2020 (Actual)
- Last update posted
- Aug 24, 2023
2018 – 2020
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital and Medical Center (SJHMC) - Barrow Neurological Institute (BNI) - The Gregory W. Fulton ALS and Neuromuscular Disease Center | Phoenix | Arizona | 85013 | — |
| HonorHealth Neurology | Phoenix | Arizona | 85018 | — |
| UC Irvine Health ALS and Neuromuscular Center | Orange | California | 92868 | — |
| University of Miami | Miami | Florida | 33136 | — |
| University of Kansas Medical Center (KUMC) - Landon Center on Aging | Kansas City | Kansas | 66160 | — |
| Hospital for Special Surgery | New York | New York | 10021 | — |
| Providence Brain & Spine Institute | Portland | Oregon | 97213 | — |
| University of Pensylvania, Perelman Center for Advanced Medicine - Penn Neuroscience Center | Philadelphia | Pennsylvania | 19107 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| University of Virginia Health System | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03491462, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2023 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03491462 live on ClinicalTrials.gov.